Entity Common Stock, Shares Outstanding of FATE THERAPEUTICS INC from 11 Nov 2013 to 19 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
FATE THERAPEUTICS INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 11 Nov 2013 to 19 Feb 2026.
  • FATE THERAPEUTICS INC Entity Common Stock, Shares Outstanding for the quarter ending 19 Feb 2026 was 116,263,459, a 1.5% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

FATE THERAPEUTICS INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 116,263,459 +1,666,034 +1.5% 19 Feb 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 115,352,289 +1,457,956 +1.3% 06 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 115,329,697 +1,451,813 +1.3% 05 Aug 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 114,597,425 +765,456 +0.67% 25 Feb 2025 10-K 05 Mar 2025 2024 FY
Q3 2024 113,894,333 +15,292,367 +16% 05 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 113,877,884 +15,315,452 +16% 06 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 113,831,969 +15,447,513 +16% 02 May 2024 10-Q 09 May 2024 2024 Q1
Q3 2023 98,601,966 +1,431,523 +1.5% 31 Oct 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 98,562,432 +1,562,138 +1.6% 02 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 98,384,456 +1,755,371 +1.8% 27 Apr 2023 10-Q 03 May 2023 2023 Q1
Q3 2022 97,170,443 +1,677,677 +1.8% 27 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 97,000,294 +1,815,747 +1.9% 28 Jul 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 96,629,085 +2,593,322 +2.8% 28 Apr 2022 10-Q 04 May 2022 2022 Q1
Q3 2021 95,492,766 +8,248,734 +9.5% 28 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 95,184,547 +8,340,518 +9.6% 02 Aug 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 94,035,763 +18,104,378 +24% 03 May 2021 10-Q 05 May 2021 2021 Q1
Q3 2020 87,244,032 +11,651,293 +15% 03 Nov 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 86,844,029 +21,458,039 +33% 03 Aug 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 75,931,385 +10,931,838 +17% 28 Feb 2020 10-K 02 Mar 2020 2019 FY
Q3 2019 75,592,739 +11,073,926 +17% 04 Nov 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 65,385,990 +11,966,801 +22% 05 Aug 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 64,999,547 +12,230,391 +23% 01 Mar 2019 10-K 05 Mar 2019 2018 FY
Q3 2018 64,518,813 +22,833,118 +55% 30 Oct 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 53,419,189 +12,003,393 +29% 03 Aug 2018 10-Q 06 Aug 2018 2018 Q2
Q1 2018 52,769,156 +11,382,650 +28% 02 Mar 2018 10-K 05 Mar 2018 2017 FY
Q3 2017 41,685,695 +7,537,541 +22% 31 Oct 2017 10-Q 01 Nov 2017 2017 Q3
Q2 2017 41,415,796 +12,520,981 +43% 14 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 41,386,506 +12,524,795 +43% 13 Mar 2017 10-K 16 Mar 2017 2016 FY
Q3 2016 34,148,154 +5,431,584 +19% 04 Nov 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 28,894,815 +200,238 +0.7% 05 Aug 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 28,861,711 +8,224,494 +40% 02 Mar 2016 10-K 03 Mar 2016 2015 FY
Q3 2015 28,716,570 +8,147,171 +40% 02 Nov 2015 10-Q 03 Nov 2015 2015 Q3
Q2 2015 28,694,577 +8,131,804 +40% 03 Aug 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 20,637,217 +201,541 +0.99% 12 Mar 2015 10-K 12 Mar 2015 2014 FY
Q3 2014 20,569,399 +212,241 +1% 11 Nov 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 20,562,773 07 Aug 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 20,435,676 13 Mar 2014 10-K 17 Mar 2014 2013 FY
Q3 2013 20,357,158 11 Nov 2013 10-Q 13 Nov 2013 2013 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.